Alk Abello Drug Patent Portfolio

Alk Abello owns 1 orange book drug protected by 8 US patents Given below is the list of Alk Abello's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11246863 Ciprofloxacin otic composition and kits and method for using same 27 Nov, 2038
Active
US11040004 Otic gel formulations for treating otitis externa 12 Nov, 2037
Active
US9220796 Sterilization of ciprofloxacin composition 01 Jul, 2035
Active
US8318817 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 27 Apr, 2030
Active
US9233068 Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders 11 Dec, 2029
Active
US11369566 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 21 Apr, 2029
Active
US9205048 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 21 Apr, 2029
Active
US9603796 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 21 Apr, 2029
Active


Given below is the list of recent legal activities going on the following drug patents of Alk Abello.

Activity Date Patent Number
Patent litigations
Expire Patent 05 Feb, 2024 US9220796
Expire Patent 15 Jan, 2024 US9205048
Maintenance Fee Reminder Mailed 21 Aug, 2023 US9220796
Maintenance Fee Reminder Mailed 31 Jul, 2023 US9205048
Recordation of Patent Grant Mailed 28 Jun, 2022 US11369566
Patent Issue Date Used in PTA Calculation 28 Jun, 2022 US11369566
Email Notification 09 Jun, 2022 US11369566
Issue Notification Mailed 08 Jun, 2022 US11369566
Application Is Considered Ready for Issue 31 May, 2022 US11369566
Dispatch to FDC 31 May, 2022 US11369566
Email Notification 31 May, 2022 US11369566
Mail Response to 312 Amendment (PTO-271) 31 May, 2022 US11369566
Response to Amendment under Rule 312 25 May, 2022 US11369566
Pubs Case Remand to TC 19 May, 2022 US11369566
Supplemental Papers - Oath or Declaration 18 May, 2022 US11369566


Alk Abello's Family Patents

Alk Abello drugs have patent protection in a total of 20 countries. It has a significant patent presence in the US with 50.5% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Alk Abello Drug List

Given below is the complete list of Alk Abello's drugs and the patents protecting them.


1. Otiprio

Otiprio is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11246863 Ciprofloxacin otic composition and kits and method for using same 27 Nov, 2038
(14 years from now)
Active
US11040004 Otic gel formulations for treating otitis externa 12 Nov, 2037
(13 years from now)
Active
US9220796 Sterilization of ciprofloxacin composition 01 Jul, 2035
(10 years from now)
Active
US8318817 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 27 Apr, 2030
(5 years from now)
Active
US9233068 Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders 11 Dec, 2029
(5 years from now)
Active
US11369566 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 21 Apr, 2029
(4 years from now)
Active
US9205048 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 21 Apr, 2029
(4 years from now)
Active
US9603796 Controlled release antimicrobial compositions and methods for the treatment of otic disorders 21 Apr, 2029
(4 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Otiprio's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List